Secure Translational Funding
The Translational Research Office (TRO) manage a number of devolved funding streams targeting early stage proof-of-concept projects and have extensive knowledge of the UK translational funding landscape. We can help source the most appropriate funding scheme for projects and ensure that the most compelling cases for support are generated. Securing funding enables projects to progress along the translational path, de-risking future investment.
Key Activities
The TRO administrate translational proof-of-concept funding through the Medical and Life Sciences Translation Fund (MLSTF). The fund is open to all University of Oxford researchers and provides consolidated internal proof of concept funding for translational medical and life sciences projects.The next call will open in 2021
The TRO also identify the most appropriate external grant funding source for a project. A few of the translational research funding schemes available to researchers are:
- Therapeutic Catalyst - Cancer Research UK (deadline: open until awarded).
- MRC Developmental Pathway Funding Scheme (next deadline for outline submission: 23 Mars 2023).
- BHF Translational Award (next deadline for preliminary and full application: 14th Mars 2022).
- NIHR Invention for Innovation: (Product Development Awards deadline for submission: 8 December 2021).
Past deadlines:
- Action Medical Research and LifeArc Translational Fund (deadline for application 9 June 2021).
- ADDF-Harrington Scholar Program (LOI submission deadline is 23 April 2021).
- The Psychiatry Consortium call for proposals: (Deadline 8 March 2020).
- Multidisciplinary Project Award Cancer Research UK (Deadline 30 January for preliminary submissions)
- Alderley Edge Oncology Development Programme (Deadline 15 January 2021).
The TRO supports developing robust project plans and compelling applications for funding. Our Translational Research Managers can support grant writing activities, provide project management support and advise on long-term translational research strategies.
The TRO works closely with Oxford University Innovation (OUI), the Medical Sciences Business Partnerships Office and University of Oxford's Research Services to ensure appropriate expertise and advice is sought at key stages in project development.